Leukemia inhibitory factor ameliorates experimental anti-GBM Ab glomerulonephritis

Kidney International

Volumn 50, Issue 6, 1996, Pages 1922-1927

  Tang, Winson W ^a   Qi, Meiying ^a   Van Gwyneth, Y ^a   Wariner, Grace P ^a   Samal, Babru ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLOMERULUS BASEMENT MEMBRANE ANTIBODY; LEUKEMIA INHIBITORY FACTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNE COMPLEX NEPHRITIS; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029987491     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.514     Document Type: Article

References (44)

1. MALKOVSKY M, SONDEL PM, STROBER W, DALGLEISH AG: The interleukins in acquired disease. Clin Exp Immunol 74:151-161, 1988
2. DINARELLO CA: Interleukin 1 and interleukin-1 antagonism. Blood 77:1627-1652, 1991
3. BEUTLER B, CERAMI A: Cachectin: More than a tumor necrosis factor. N Engl J Med 316:379-285, 1987
4. MILLER MD, KRANGEL MS: Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17-46, 1992
5. SPRENGER TA: Adhesion receptors of the immune system. Nature 346:425-434, 1990
6. BEVILACQUA MP, POBER JS, MAJEAU RS, FIERS W, COTRAN RS, GIMBRONE MA JR: Recombinant tumor necrosis factor induces procoagulant activity in cultured human endothelium: Characterization and comparison with the actions of interleukin-1. Proc Natl Acad Sci USA 83:4533-4537, 1986
7. DAYER JM, BEUTLER B, CERAMI A: Cachetin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168, 1985
8. SHALABY MR, AGGARWAL BG, RINDERKNECHT E, SVEDERSKY LP, FINKLE BS, PALLADINO MA JR: Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factor. J Immunol 135:2069-2073, 1985
9. JORDAN M, OTTERNESS IG, NG R, GESSNER A, ROLLINGHOFF M, BEUSCHER HU: Neutralization of endogenous IL-6 suppresses induction of Il-1 receptor antagonist. J Immunol 154:4081-4090, 1995
10. KLINE JN, FISHER PA, MONICK MM, HUNNINGHAKE GW: Regulation of interleukin-1 receptor antagonist by Th1 and Th2 cytokines. Am J Physiol 269:L92-L98, 1995
11. EISENBERG SP, EVANS RJ, AREND WP, VERDERBER E, BREWER MT, HANNUM CH, THOMPSON RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343:341-346, 1990
12. 2. Proc Natl Acad Sci USA 86:3803-3807, 1989
13. PELEMAN R, WU JC, FARGEAS C, DELESPESSE G: Recombinant interleukin 4 suppresses the production of interferon γ by human mononuclear cells. J Exp Med 170:1751-1756, 1989
14. DE WAAL MALEFYT R, ABRAMS RJ, BENNETT B, FIGDOR CG, DE VRIES JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
15. CASTELLA MA, MEDA L, BONORA S, CESKA M, CONSTANTIN G: Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes: Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178: 2207-2211, 1993
16. TANG WW, FENG L, VANNICE JL, WILSON CB: Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement antibody-associated glomerulonephritis. J Clin Invest 93:273-279, 1994
17. HRUBY ZW, SHIROTA K, JOTHY S, LOWRY RP: Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injury. Kidney Int 40:43-51, 1991
18. REES AJ: Inhibition of pro-inflammatory cytokines in glomerulonephritis. XIIIth International Congress of Nephrology, Madrid, July 2-6, 1995, p 73 (abstract)
19. METCALF D: The leukemia inhibitory factor. Int J Cell Cloning 9:95-108, 1991
20. KISHIMOTO T, AKIRA S, NARAZAKI M, TAGA T: Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254, 1995
21. ULICH TR, FANN M-J, PATTERSON PH, WILLIAMS JH, SAMAL B, DEL CASTILLO J, YIN S, GUO K, REMICK DG: Intratracheal injection of LPS and cytokines. V. LPS induces expression of IIF and LIF inhibits acute inflammation. Am J Physiol 267:L442-L446, 1994
22. WARING PM, WYCHERLEY K, CARY D, NICOLA N, METCALF D: Leukemia inhibitory levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 90:2031-2037, 1992
23. WARING PM, WARING LJ, BILLINGTON T, METCALF D: Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. Proc Natl Acad Sci USA 92:1337-1341, 1995
24. ALEXANDER HR, WONG GGH, DOHERTY GM, VENZON DJ, FRAKER DL, NORTON JA: Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: Synergistic effect with interleukin 1 and tumor necrosis factor. J Exp Med 175:1139-1142, 1992
25. BLOCK MI, BERG, M, MCNAMARA MJ, NORTON JA, FRAKER DL, ALEXANDER HR: Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia. J Exp Med 178:1085-1090, 1993
26. SAMAL BB, ARAKAWA T, BOONE TC, JONES T, PRESTRELSKI SJ, NARHI LO, WEN J, CRANDALL CA, POPE J, SUGGS S: High level expression of human leukemia inhibitory factor (LIF) from a synthetic gene in Escherichia coli and the physical and biological properties of the protein. Biochim Biophys Acta 1260:27-34, 1995
27. YAMAMORI T, FUKADA K, AEBERSOLD RH, KORSCHING S, FANN M-J, PATTERSON PH: The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 246:1412-1416, 1989
28. SHIRAI T, SHIMIZU N, HORIGUCHI S, ITO H: Cloning and expression in Escherichia coli of the gene for tumor necrosis factor. Agric Biol Chem 53:1733-1736, 1989
29. MARCH CJ, MOSLEY B, LARSEN A, CERRETTI DP, BRAEDT G, PRICE V, GILLIS S, HENNEY CS, KRONHEIM SR, GRABSTEIN K, CONLON PJ, HOPP TP, COSMAN D: Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641-647, 1985
30. TELFORD JL, MACCHIA G, MASSONE A, CARINCI V, PALLA E, MELLI M: The murine interleukin 1β gone: Structure and function. Nuc Acid Res 14:9955-9963, 1986
31. TANG WW, YIN S, WITTWER AJ, QI M: Chemokine gene expression in anti-glomerular basement membrane antibody glomerulonephritis. Am J Physiol 269:F323-F330, 1995
32. LOTZ M, MOATS T, VILLIGER PM: Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest 90:888-896, 1992
33. TAUPIN JL, MOREL D, MOREAU JF, GUALDE N, POTAUX L, BEZIAN J-H: HILDA/LIF urinary excretion during acute kidney rejection. Transplantation 53:655-658, 1992
34. TOMIDA M, YAMAMOTO-YAMAGUCHI Y, HOZUMI M: Purification of a factor inducing proliferation of mouse myeloid leukemia M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 259:10978-10982, 1984
35. ANEGON I, MOREAU J-F, GODARD A, JACQUES Y, PEYRAT M-A, HALLET M-M, WONG G, SOULILLOU JP: Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol 130:50-65, 1990
36. ISHIMI Y, ABE E, JIN CH, MIYAURA C, HONG MH, OSHIDA M, KUROSAWA H, YAMAGUCHI Y, TOMIDA M, HOZUMI M, SUDA T: Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-Factor): Regulation of its production and possible role in bone metabolism. J Cell Physiol 152:71-78, 1992
37. GEARING DP, GOUGH NM, KING JA, HILTON DJ, NICOLA NA, SIMPSON RJ, NICE EC, KELSO A, METCALF D: Molecular cloning and expression of cDNA encoding a murine leukaemia inhibitory factor (LIF). EMBO J 6:3995-4002, 1987
38. GROSSET C, JAZWIEC B, TAUPIN J-L, LIU H, RICHARD S, MAHON F-X, REIFFERS J, MOREAU J-F, RIPOCHE J: In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: Differential regulation by interleukin-1α and glucocorticoids. Blood 86:3763-3770, 1995
39. LOVETT DH, SZAMEL M, RYAN JL, STERZELL RB, GEMSA D, RESCH K: Interleukin-1 and the glomerular mesangium. I. Purification and characterization of mesangial cell-derived autogrowth factor. J Immunol 136:3700-3705, 1986
40. RUEF C, BUDDE K, LACY J, NORTHEMAN W, BAUMANN M, STERZELL RB, COLEMAN DL: Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int 38:249-257, 1990
41. BAUD L, OUDIENT J-P, BENS M, NOE L, PERALDI M-N, RONDEAU E, ETIENNE J, ARDAILLOU R: Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 35:1111-1118, 1989
42. FOUQUERAY B, PHILIPPE C, BOUTARD V, KORNREICH A, MARCHANT A, PEREZ J, GOLDMAN M, BAUD L: Mesangial cell-derived Interleukin-10 modulates MC response to lipopolysaccharide. Am J Pathol 147:176-182, 1995
43. HILTON DJ, NICOLA NA, WARING PM, METCALF D: Clearance and fate of leukemia-inhibitory factor (LIF) after injection into mice. J Cell Physiol 148:430-439, 1991
44. TANG WW, QI M, WARREN JS: The role of monocyte chemoattractant protein-1 (MCP-1) in anti-GBM Ab GN. Kidney Int 50:665-671, 1946